Enhancement of antitumor natural killer cell activation by orally administered Spirulina extract in mice

Cancer Science

Volumn 100, Issue 8, 2009, Pages 1494-1501

  Akao, Yuusuke ^a   Ebihara, Takashi ^a   Masuda, Hisayo ^b,d   Saeki, Yoshiko ^b   Akazawa, Takashi ^b   Hazeki, Kaoru ^c   Hazeki, Osamu ^c   Matsumoto, Misako ^a,b   Seya, Tsukasa ^a,b  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Osaka Medical Center for Cancer   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

^d NARA INSTITUTE OF SCIENCE AND TECHNOLOGY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD8BETA ANTIBODY; CELL PROTEIN; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; LYMPHOCYTE ANTIBODY; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MICROBIAL PRODUCTS NOT CLASSIFIED ELSEWHERE; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN RAE 1; SPIRULINA PLATENSIS EXTRACT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CELL WALL; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; MELANOMA; MOUSE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPIRULINA PLATENSIS; SPLEEN; WILD TYPE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, ORAL; ANIMALS; BCG VACCINE; BONE MARROW CELLS; CELL WALL; DENDRITIC CELLS; DRUG SYNERGISM; FEMALE; INTERFERON-GAMMA; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYELOID DIFFERENTIATION FACTOR 88; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; POWDERS; SPECIFIC PATHOGEN-FREE ORGANISMS; SPIRULINA; SPLEEN; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 67650663994     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2009.01188.x     Document Type: Article

References (42)

1. Medzhitov R, Janeway CA Jr. Innate immunity: The virtues of a nonclonal system of recognition. Cell 1997; 91: 295-8.
2. Takeda Y, Kaisho T, Akira S. Toll-like receptors. Annu Rev Immunol 2003; 21: 335-76.
3. Furrie E, Macfarlane S, Thomson G, Macfarlane GT, George T. Toll-like receptors-2, -3 and -4 expression patterns on human colon and their regulation by mucosal-associated bacteria. Immunology 2005; 115: 565-74.
4. Dostert C, Meylan E, Tschopp J. Intracellular pattern-recognition receptors. Adv Drug Deliv Rev 2008; 60: 830-40.
5. Belay A. Spirulina (Arthrospira): Production and quality assurance. In: Gershwin ME, Belay A, eds. Spirulina in human nutrition and health. New York: CRC Press, 2007; 1-25.
6. Tornabene TG, Bourne TF, Raziuddin S, Ben-Amotz A. Lipid and lipopolysaccharide constituents of cyanobacterium Spirulina platensis (Cyanophyceae, Nostocales). Mar Ecol 1985; 22: 121-5.
7. Dillon JC, Phuc AC, Dubacq JP. Nutritional value of the alga Spirulina. World Rev Nutr Diet 1995; 77: 32-46.
8. Hayashi T, Hayashi K, Maeda M, Kojima I. Calcium spirulan, an inhibitor of enveloped virus replication, from a blue-green alga Spirulina platensis. J Nat Prod 1996; 59: 83-7.
9. Hayashi O, Katoh T, Okuwaki Y. Enhancement of antibody production in mice by dietary Spirulina platensis. J Nutr Sci Vitaminol (Tokyo) 1994; 40: 431-41.
10. Mao TK, Van de Water J, Gershwin ME. Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients. J Med Food 2005; 8: 27-30.
11. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T. Activation of the human innate immune system by spirulina: Augmentation of interferon gamma production and NK cytotoxicity by oral administration of spirulina. Int Immunopharmac 2002; 2: 423-34.
12. Seya T, Akazawa T, Matsumoto M, Begum NA, Azuma I, Toyoshima K. Innate immune therapy for cancer: Application of BCG-CWS and spirulina to patients with lung cancer. Anticancer Res 2003; 23: 4369-76.
13. Tsuji S, Matsumoto M, Takeuchi O et al. Maturation of human dendritic cells by cell-wall skeleton of Mycobacterium bovis Bacillus Calmette-Guerin: Involvement of Toll-like receptors. Infect Immun 2000; 68: 6883-90.
14. Uehori J, Tsuji S, Matsumoto M et al. Simultaneous blocking of human Toll-like receptor 2 and 4 suppresses myeloid dendritic cell maturation induced by Mycobacterium bovis bacillus Calmette-Guérin (BCG) -peptidoglycan (PGN). Infect Immun 2003; 71: 4238-49.
15. Akazawa T, Masuda H, Saeki Y et al. Adjuvant-mediated tumor regression and tumor-specific CTL induction are impaired in MyD88-deficient mice. Cancer Res 2004; 64: 757-64.
16. Masuda H, Saeki Y, Nomura M et al. High levels of RAE-1 isoforms on mouse tumor cell lines assessed by anti-'pan'RAE-1 antibody confer tumor susceptibility to NK cells. Biochem Biophys Res Commun 2002; 290: 140-5.
17. Akazawa T, Okuno M, Okuda Y et al. Antitumor NK activation induced by the Toll-like receptor3-TICAM-1 (TRIF) pathway in myeloid dendritic cells. Proc Natl Acad Sci USA 2007; 104: 252-7.
18. Quoc KP, Dubacq JP. Effect of growth temperature on the biosynthesis of eukaryotic lipid molecular species by the cyanobacterium Spirulina platensis. Biochim Biophys Acta 1997; 1346: 237-46.
19. Azuma I, Ribi EE, Meyer TJ, Zbar B. Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. J Natl Cancer Inst 1974; 52: 95-101.
20. Tanaka H, Mori Y, Ishii H, Akedo H. Enhancement of metastatic capacity of fibroblast-tumor cell interaction in mice. Cancer Res 1988; 48: 1456-9.
21. Saeki Y, Seya T, Hazeki O, Hazeki K, Ui M, Akedo H. Phosphatidylinositol 3 kinase inhibitors block matrix adhesion and experimental metastasis of high metastatic mouse hepatoma clones. J Biochem (Tokyo) 1998; 124: 1020-5.
22. Uenaka A, Ono T, Akisawa T, Wada H, Yasuda T, Nakayama E. Identification of a unique antigen peptide pRL1 on BALB/c RL male 1 leukemia recognized by cytotoxic T lymphocytes and its relation to the Akt oncogene. J Exp Med 1994; 180: 1599-607.
23. Ebihara T, Masuda H, Akazawa T et al. NKG2D ligands are induced on human dendritic cells by TLR ligand stimulation and RNA virus infection. Int Immunol 2007; 19: 1145-55.
24. Nishiguchi M, Matsumoto M, Takao T et al. Mycoplasma fermentans lipoprotein M161Ag-induced cell activation is mediated by Toll-like receptor 2: Role of N-terminal hydrophobic portion in its multiple functions. J Immunol 2001; 166: 2610-6.
25. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C (T) method. Methods 2001; 25: 402-8.
26. Hayashi A, Noda A. Does the cell wall skeleton from Bacille Calmette-Guerin directly induce interferon-gamma, independent of interleukin-12? Jpn J Clin Oncol 1996; 26: 124-7.
27. Seya T, Matsumoto M. The extrinsic RNA-sensing pathway for adjuvant immunotherapy of cancer. Cancer Immunol Immunother 2009, January 31 [Epub ahead of print].
28. Seya T, Hazeki K, Inoue N, Matsumoto M. Pattern-recognition confers driving various cellular effectors on dendritic cells. Cancer Sci 2009; in press.
29. Hayakawa Y, Smyth MJ. NKG2D and cytotoxic effector function in tumor immune surveillance. Semin Immunol 2006; 18: 176-85.
30. Moretta L, Ferlazzo G, Bottino C et al. Effector and regulatory events during natural killer-dendritic cell interactions. Immunol Rev 2006; 214: 219-28.
31. Gerosa F, Baldani-Guerra B, Nisii C, Marchesini V, Carra G, Trinchieri G. Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 2002; 195: 327-33.
32. Matsumoto M, Seya T. TLR3 signaling inducing IFN in response to dsRNA and polyI. C Adv Drug Deliv Rev 2008; 60: 805-12.
33. Seya T, Ebihara T, Kodama K, Hazeki K, Matsumoto M. NK activation induced by Spirulina. In: Gershwin ME, Belay A, eds. Spirulina in human nutrition and health. New York: CRC Press, 2007, 195-203.
34. Pisegna S, Pirozzi G, Piccoli M, Frati L, Santoni A, Palmieri G. p38 MAPK activation controls the TLR3-mediated up-regulation of cytotoxicity and cytokine production in human NK cells. Blood 2004; 104: 4157-64.
35. Mathew B, Sankaranarayanan R, Nair PP et al. Evaluation of chemoprevention of oral cancer with Spirulina fusiformis. Nutr Cancer 1995; 24: 197-202.
36. Mishima T, Murata J, Toyoshima M et al. Inhibition of tumor invasion and metastasis by calcium spirulan (Ca-SP), a novel sulfated polysaccharide derived from a blue-green alga, Spirulina platensis. Clin Exp Metastasis 1998; 16: 541-50.
37. Ramaswamy G, Rao VR, Kumaraswamy SV, Anantha N. Serum vitamins'status in oral leucoplakias: A preliminary study. Eur J Cancer B Oral Oncol 1996; 32B: 120-2.
38. Pappalardo G, Maiani G, Mobarhan S et al. Plasma (carotenoids, retinol, alpha-tocopherol) and tissue (carotenoids) levels after supplementation with beta-carotene in subjects with precancerous and cancerous lesions of sigmoid colon. Eur J Clin Nutr 1997; 51: 661-6.
39. Mao TK, Van de Water J, Gershwin ME. Effects of Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients. J Med Food 2005; 8: 27-30.
40. Cerwenka A, Lanier LL. Natural killer cells, viruses and cancer. Nat Rev Immunol 2001; 1: 41-9.
41. Kodama K, Higashiyama M, Takami K et al. Innate immune therapy with a BCG cell wall skeleton for lung cancer: A case presentation and a case control study. Surg Today 2009; 39: 194-200.
42. Alexandroff AB, Jackson AM, O'Donnell MA, James K. BCG immunotherapy of bladder cancer: 20 years on. Lancet 1999; 353: 1689-94.